Equity Overview
Price & Market Data
Price: $0.0282
Daily Change: $0.00 / 0.00%
Daily Range: $0 - $0
Market Cap: $62,550,348
Daily Volume: 0
Performance Metrics
1 Week: -2.08%
1 Month: -31.22%
3 Months: -64.42%
6 Months: -70.25%
1 Year: -88.72%
YTD: -68.49%
Details
Botanix Pharmaceuticals Limited operates as a commercial dermatology company in Australia and the United States. The company's lead product is Sofdra (sofpironium) topical gel, a prescription anticholinergic medicine used on the skin to treat underarm sweating in adults and children 9 years of age and older. Its product pipeline includes BTX 1503, a transdermal gel formulation for the treatment of serious acne in adults and teenagers; BTX 1801 for treating staphylococcus aureus and methicillin resistant staphylococcus aureus; BTX 1702 for the treatment of papulopustular rosacea; and BTX 1204A for treating atopic dermatitis. The company was incorporated in 1984 and is based in West Perth, Australia.